Condition: Pharmacology


CBD and the 5-HT1A receptor: A medicinal and pharmacological review

Please use this link to access this publication. Abstract Cannabidiol (CBD), a phytocannabinoid, has emerged as a promising candidate for addressing a wide array of symptoms. It has the ability…

Pharmacological properties, therapeutic potential, and legal status of Cannabis sativa L.: An overview

Please use this link to access this publication. Abstract Marijuana, or Cannabis sativa L., is a common psychoactive plant used for both recreational and medicinal purposes. In many countries, cannabis-based medicines have…

Identification of the TRPA1 cannabinoid-binding site

Abstract Chronic pain accounts for nearly two-thirds of conditions eligible for medical cannabis licenses, yet the mechanisms underlying cannabis-induced analgesia remain poorly understood. The principal phytocannabinoids, the psychoactive Δ9-tetrahydrocannabinol (THC)…

Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users

Please use this link to access this publication. Abstract Introduction The use and availability of oral and inhalable products containing cannabidiol (CBD) as the principal constituent has increased with expanded…

Cannabis and cannabinoids: pharmacology and therapeutic potential

Abstract Introduction. Cannabis (also known as marijuana) is the most frequently used psychoactive substance in the world. The role of cannabis in medicine is rapidly evolving, and advances in the…

Cannabis for Medical Use: Clinical Pharmacology Perspectives on Scientific and Regulatory Challenges

Abstract There has been growing interest in developing therapeutic agents and other consumer products derived from cannabis and its components. To date, the US Food and Drug Administration (FDA) has…

Pharmacology of Minor Cannabinoids at the Cannabinoid CB1 Receptor: Isomer- and Ligand-Dependent Antagonism by Tetrahydrocannabivarin

Abstract Background: In addition to the major phytocannabinoids, trans-Δ9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD), the cannabis plant (Cannabis sativa L.) synthesizes over 120 additional cannabinoids that are known as minor cannabinoids. These minor…

A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)

Abstract Cannabidiol (CBD) is an abundant non-psychoactive phytocannabinoid in cannabis extracts which has high affinity on a series of receptors, including Type 1 cannabinoid receptor (CB1), Type 2 cannabinoid receptor…

Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications

Abstract Background Medical cannabinoids differ in their pharmacology and may have different treatment effects. We aimed to conduct a pharmacology-based systematic review (SR) and meta-analyses of medical cannabinoids for efficacy,…

Serum-dependent effects of tamoxifen and cannabinoids upon C6 glioma cell viability

Please use this link to access this publication. Abstract In the present study, the effects of the combination of tamoxifen ((Z)-2[p-(1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethylamine citrate) and three cannabinoids (Δ9-tetrahydrocannabinol [Δ9-THC], cannabidiol, and anandamide [AEA]) upon the viability of…